Showing results (221-230 of 244) with videos related to

Sort By:
Pageof 25
The Canadian Journal of Urology|April 21, 2011
Comparison of accuracy among three generations of Partin tables in a Chinese cohortWen-Jun Xiao, Ding-Wei Ye, Xu-Dong Yao, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 9, 2010
[The survival analysis of the advanced metastatic castration-resistant prostate cancer]Chun-guang Ma, Ding-wei Ye, Xu-dong Yao, et al.
BJU International|November 11, 2014
Visceral fat accumulation is associated with different pathological subtypes of renal cell carcinoma (RCC): a multicentre study in ChinaHong-Kai Wang, Xi-Shuang Song, Yue Cheng, et al.
Plos One|January 28, 2015
A multicenter, randomized clinical trial comparing the three-weekly docetaxel regimen plus prednisone versus mitoxantone plus prednisone for Chinese patients with metastatic castration refractory prostate cancerTie Zhou, Shu-xiong Zeng, Ding-wei Ye, et al.
BJU International|March 17, 2020
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinomaMarco Bandini, Maarten Albersen, Juan Chipollini, et al.
Urologic Oncology|October 4, 2021
Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinomaNicholas H Chakiryan, Aaron Dahmen, Marco Bandini, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|November 9, 2010
[The survival analysis of metastatic prostate cancer]Chun-Guang Ma, Ding-Wei Ye, Xu-Dong Yao, et al.
Asian Journal of Andrology|March 16, 2016
Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonographyGuo-Peng Yu, Rong Na, Ding-Wei Ye, et al.
The Journal of Urology|May 25, 2021
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance StrategiesNicholas H Chakiryan, Aaron Dahmen, Marco Bandini, et al.
Asian Journal of Andrology|June 16, 2023
Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trialByung Ha Chung, Jian Huang, Hiroji Uemura, et al.
Pageof 25